Treasury teams are under pressure to operate in a real-time, data-driven environment, yet many still rely on fragmented ...
After two decades of growth driven largely by scale and generics, 2025 proved to be a reset year for India’s pharmaceutical, healthcare and medical devices sectors. Policy reform, a renewed focus on ...